| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.240 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.210 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 1984 | 2017 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
beclin 1 | 0.432 | 0.846 | 0.94 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
group | 0.530 | None | 1.000 | 2 | 0 | 1997 | 2018 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 1997 | 2011 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
microtubule associated protein tau | 0.446 | 0.923 | 6.0E-03 |
|
group | 0.700 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.984 | 1 | 0 | 1997 | 2020 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 |